Metraipolis › archive › dc_7cb21eb9b4e2

Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42195263
DOI: 10.3390/life16050708
License (as archived): solo-consultazione
Archived: 2026-11-03T07:44:18.639Z
SHA-256 of the archived text: 01d268313c7f76a8a7a319ca54dd8cc3a8142e4c94377c17294949775c95f6aa
Stable URL of this page: https://metraipolis.com/documento/dc_7cb21eb9b4e2

How to cite

Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263 — Europe PMC (en), https://europepmc.org/article/MED/42195263 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7cb21eb9b4e2 (Metraipolis archive dc_7cb21eb9b4e2, sha256 01d268313c7f76a8a7a319ca54dd8cc3a8142e4c94377c17294949775c95f6aa)

BibTeX

@misc{dc7cb21eb9b4e2,
  title = {Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42195263},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7cb21eb9b4e2; sha256 01d268313c7f76a8a7a319ca54dd8cc3a8142e4c94377c17294949775c95f6aa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195263. Agents can read the archived copy with the MCP tool read_document.